Corporate News* Aurobindo Pharma board approves buyback plan worth Rs 750 cr. Bank of India raises Rs 5,000 crore via 10-year infrastructure bonds. CEAT Q1 results: Profit rises 2.74% to Rs 149.79 cr, revenue up 8.79%. #FinancialNews #StockMarket #Investment #Trading Corporate News* Aurobindo Pharma board approves buyback plan worth Rs 750 cr. Bank of India raises Rs 5,000 crore via 10-year infrastructure bonds. CEAT Q1 results: Profit rises 2.74% to Rs 149.79 cr, revenue up 8.79%. #FinancialNews #StockMarket #Investment #Trading